TarChoon Aw | Chemical Pathology | Best Researcher Award

Prof. Dr. TarChoon Aw | Chemical Pathology | Best Researcher Award

Professor (Pathology) at Duke-NUS Graduate Medical School, Singapore

Dr. Tar-Choon Aw is a distinguished clinician-scientist recognized for his contributions to clinical biochemistry and laboratory medicine. With over four decades of experience, Dr. Aw has held pivotal roles that have shaped advancements in metabolic disease research and improved patient care in clinical laboratories worldwide. His expertise spans metabolic and lipid disorders, with a special emphasis on biochemical markers that can aid in the early diagnosis of these conditions. As a member of multiple professional societies, he has collaborated with international experts to innovate and refine laboratory practices. Dr. Aw’s extensive research portfolio includes influential publications and impactful studies on metabolic diseases, where his insights into the biochemical underpinnings of disease have led to more refined, reliable diagnostic techniques. As a professor and mentor, he is dedicated to training future clinicians and researchers, underscoring his commitment to the next generation of healthcare professionals.

Education

Dr. Tar-Choon Aw’s academic background is as impressive as it is comprehensive. He earned his medical degree with honors, followed by a specialization in clinical biochemistry, which laid the foundation for his expertise in metabolic disorders and laboratory medicine. Dr. Aw pursued further postgraduate studies in the United States and Europe, completing prestigious fellowships that deepened his knowledge in metabolic disease diagnostics and laboratory technologies. Throughout his academic career, he maintained a strong interest in biochemical research, particularly in the areas of metabolic diseases and endocrinology. His educational journey has endowed him with a broad yet nuanced understanding of biochemistry and clinical applications, which he continues to utilize in his ongoing research. Dr. Aw’s commitment to lifelong learning has been a central pillar in his career, leading him to contribute significantly to the field of clinical biochemistry.

Professional Experience

Dr. Tar-Choon Aw’s professional experience includes key roles in academic, clinical, and research institutions, which have equipped him with a well-rounded perspective in laboratory medicine. As a professor and researcher at prominent medical institutions, Dr. Aw has been instrumental in the development of new laboratory protocols and the implementation of diagnostic tools that have advanced the field of clinical biochemistry. His roles have ranged from directing clinical laboratories to advising on biochemistry panels used for metabolic and lipid disorder diagnostics, directly impacting patient care through improved testing accuracy and reliability. Additionally, Dr. Aw has held leadership positions within professional societies, where he has contributed to establishing standards and guidelines for clinical laboratory practice. His work in diverse healthcare settings has underscored his commitment to both patient outcomes and advancing laboratory medicine as a discipline.

Research Interest

Dr. Tar-Choon Aw’s research focuses on metabolic and lipid disorders, particularly in understanding and identifying biomarkers that can signal early disease onset. His interests extend to biochemical diagnostics, with an emphasis on developing assays and laboratory techniques that improve the precision of metabolic disorder diagnoses. Dr. Aw is particularly engaged in studying how lipid metabolism impacts chronic diseases like cardiovascular conditions and diabetes, striving to elucidate biochemical pathways that may serve as targets for therapeutic intervention. His research has also explored the application of emerging technologies, such as high-throughput screening and bioinformatics, in the identification of novel biomarkers for metabolic conditions. Dr. Aw’s commitment to research that bridges laboratory science with clinical application has made his work invaluable to both scientific and medical communities.

Research Skills

Dr. Tar-Choon Aw is equipped with a diverse set of research skills, including advanced biochemical assay development, laboratory diagnostics, and proficiency in statistical analysis for clinical data. His expertise in laboratory medicine is complemented by his knowledge of molecular biology techniques, which he employs to investigate metabolic pathways. Dr. Aw is adept at employing both traditional and innovative laboratory methods to study lipid and metabolic biomarkers, and he has extensive experience with high-throughput screening methods that enhance diagnostic precision. His analytical skills allow him to interpret complex clinical data, making him a valuable contributor to studies that seek to improve the understanding of metabolic diseases. Dr. Aw’s commitment to detail and precision in his research methodology has set a high standard in the field, earning him respect from colleagues and collaborators alike.

Awards and Honors

Dr. Tar-Choon Aw’s contributions to clinical biochemistry and laboratory medicine have been recognized through numerous awards and honors. He has received several prestigious accolades from international professional societies in recognition of his pioneering work in metabolic disease diagnostics and laboratory technology innovation. Additionally, he has been awarded for his teaching excellence, particularly in training young scientists and clinicians in laboratory medicine. His research publications, which have significantly impacted metabolic disorder diagnostics, have been recognized by leading medical journals and have earned him various accolades for scientific excellence. Dr. Aw’s dedication to his field has garnered him numerous honorary memberships and invitations to speak at international conferences, underscoring the global impact of his work in advancing clinical biochemistry and laboratory medicine.

Conclusion

Dr. Tar-Choon AW exemplifies an exceptional candidate for the Best Researcher Award in recognition of his lifelong contributions to clinical chemistry and pathology, extensive research output, and leadership in laboratory medicine. His achievements are reflective of a career dedicated to advancing both the scientific and clinical aspects of pathology on an international scale. While he could enhance his portfolio with expanded interdisciplinary research, Dr. AW’s distinguished career and significant impact on laboratory medicine make him a strong contender for this award.

Publications Top Notes

  • Interaction of cells and nanofiber scaffolds in tissue engineering
    Authors: J. Venugopal, S. Low, A.T. Choon, S. Ramakrishna
    Journal: Journal of Biomedical Materials Research Part B: Applied Biomaterials
    Year: 2008
    Citations: 397
  • Aligned and random nanofibrous substrate for the in vitro culture of Schwann cells for neural tissue engineering
    Authors: D. Gupta, J. Venugopal, M.P. Prabhakaran, V.R.G. Dev, S. Low, A.T. Choon, …
    Journal: Acta Biomaterialia
    Year: 2009
    Citations: 362
  • Nanobioengineered electrospun composite nanofibers and osteoblasts for bone regeneration
    Authors: J.R. Venugopal, S. Low, A.T. Choon, A.B. Kumar, S. Ramakrishna
    Journal: Artificial Organs
    Year: 2008
    Citations: 296
  • Central obesity, insulin resistance, syndrome X, lipoprotein (a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore
    Authors: K. Hughes, T.C. Aw, P. Kuperan, M. Choo
    Journal: Journal of Epidemiology & Community Health
    Year: 1997
    Citations: 272
  • Mineralization of osteoblasts with electrospun collagen/hydroxyapatite nanofibers
    Authors: J. Venugopal, S. Low, A.T. Choon, T.S. Sampath Kumar, S. Ramakrishna
    Journal: Journal of Materials Science: Materials in Medicine
    Year: 2008
    Citations: 245
  • Biomimetic hydroxyapatite-containing composite nanofibrous substrates for bone tissue engineering
    Authors: J. Venugopal, M.P. Prabhakaran, Y. Zhang, S. Low, A.T. Choon, …
    Journal: Philosophical Transactions of the Royal Society A: Mathematical, Physical …
    Year: 2010
    Citations: 238
  • Laboratory Testing in Thyroid Conditions-Pitfalls and Clinical Utility
    Authors: S.B. Soh, T.C. Aw
    Journal: Annals of Laboratory Medicine
    Year: 2019
    Citations: 178
  • Electrospun‐modified nanofibrous scaffolds for the mineralization of osteoblast cells
    Authors: J. Venugopal, S. Low, A.T. Choon, A.B. Kumar, S. Ramakrishna
    Journal: Journal of Biomedical Materials Research Part A: An Official Journal of The …
    Year: 2008
    Citations: 176
  • Housing a healthy, educated, and wealthy nation through the CPF
    Authors: L. Low, T.C. Aw
    Source: Institute of Policy Studies
    Year: 1997
    Citations: 163
  • Nanotechnology for nanomedicine and delivery of drugs
    Authors: J. Venugopal, M.P. Prabhakaran, S. Low, A.T. Choon, Y.Z. Zhang, G. Deepika, …
    Journal: Current Pharmaceutical Design
    Year: 2008
    Citations: 143

 

Kyu Sang Lee | Pathology | Best Researcher Award

Prof Dr. Kyu Sang Lee | Pathology | Best Researcher Award

Professor at Seoul National University Bundang Hospital, South Korea

Dr. Kyu Sang Lee is an Associate Professor in the Department of Pathology at Seoul National University Bundang Hospital, South Korea. He holds an MD from Eulji University and a PhD in Translational Medicine from Seoul National University College of Medicine. With extensive experience in pathology, Dr. Lee has contributed significantly to cancer research, publishing numerous high-impact articles in esteemed journals. He is recognized for his innovative work, including the development of an AI-powered PD-L1 combined positive score analyzer, which has implications for cancer diagnostics. Dr. Lee has received multiple awards for his research presentations, showcasing his peers’ acknowledgment of his contributions. Additionally, he is an active member of several professional pathology societies, reflecting his commitment to advancing the field. As a dedicated educator, he plays a vital role in training future pathologists, making him a prominent figure in the pathology community.

Professional Profiles:

Education

Dr. Kyu Sang Lee has an impressive educational background that underscores his expertise in the field of pathology. He earned his Doctor of Medicine (M.D.) degree from Eulji University, College of Medicine, in Daejeon, Korea, in 2008. Following this, he pursued further specialization in neuroscience, obtaining a Master of Science (M.S.) degree from Seoul National University College of Medicine in 2012. Dr. Lee continued to advance his academic credentials by completing his Doctor of Philosophy (Ph.D.) in Translational Medicine at the same institution in 2018. His educational journey has equipped him with a comprehensive understanding of both clinical and research aspects of pathology, providing a solid foundation for his subsequent roles in academia and clinical practice. This rigorous training has enabled Dr. Lee to make significant contributions to the field, particularly in cancer research and diagnostics, positioning him as a leader in his discipline.

Experiences

Dr. Kyu Sang Lee is an accomplished academic and medical professional currently serving as an Associate Professor in the Department of Pathology at Seoul National University Bundang Hospital. His career began with a residency in Pathology at Seoul National University Hospital, where he developed a strong foundation in diagnostic pathology. He advanced through various roles, including Instructor and Fellow, before becoming an Assistant Professor in 2017. Dr. Lee further expanded his expertise as a Visiting Professor at the University of California, Los Angeles, from 2021 to 2023. His research has focused on translational medicine and cancer pathology, with significant contributions to artificial intelligence applications in diagnostics. Dr. Lee has published extensively, including notable works on urothelial carcinoma and glioblastoma, and has received multiple awards for his research presentations at international conferences. His professional experience reflects a commitment to advancing pathology through research, education, and clinical practice.

Research Interest

Dr. Kyu Sang Lee’s research interests lie primarily in the field of pathology, with a strong focus on cancer diagnostics and therapeutics. He is particularly engaged in exploring the molecular and cellular mechanisms underlying various cancers, including glioblastoma and colorectal cancer. His work involves utilizing advanced techniques such as next-generation sequencing and artificial intelligence to improve the accuracy and efficiency of cancer diagnosis, particularly in identifying biomarkers for targeted therapies. Dr. Lee is also interested in the implications of immune checkpoint proteins, such as PD-L1, in tumor biology and their potential as therapeutic targets. Additionally, he studies the clinicopathologic characteristics of different tumor types, aiming to enhance personalized medicine approaches. His commitment to translational research ensures that his findings have practical applications in clinical settings, ultimately contributing to improved patient outcomes and advancing the field of oncology.

Teaching Experience

Dr. Kyu Sang Lee has extensive teaching experience in the field of pathology, contributing significantly to the education and training of medical students and residents at Seoul National University Bundang Hospital. As an Associate Professor, he teaches both undergraduate and graduate courses, focusing on core subjects such as anatomical pathology and diagnostic techniques. His instructional approach emphasizes hands-on learning and critical thinking, enabling students to develop practical skills and a deep understanding of pathology. Dr. Lee has also supervised numerous residents and fellows, providing mentorship and guidance in their clinical and research endeavors. His commitment to education is further demonstrated through his participation in various seminars and workshops, where he shares his expertise on emerging topics in pathology, including artificial intelligence applications in diagnostics. By fostering a collaborative and interactive learning environment, Dr. Lee plays a crucial role in preparing the next generation of pathologists for their future careers.

Academic Achievements and Activities

Dr. Kyu Sang Lee is an accomplished academic with a strong foundation in pathology, holding an MD from Eulji University and a PhD in Translational Medicine from Seoul National University College of Medicine. Currently, he serves as an Associate Professor at the Department of Pathology at Seoul National University Bundang Hospital, where he has been instrumental in advancing the field through his innovative research. His work has garnered multiple accolades, including Best Poster awards at renowned international congresses, highlighting his contributions to cancer diagnostics and treatment. Dr. Lee’s research includes the development of an AI-powered PD-L1 analyzer and studies on microsatellite instability in colorectal cancer, demonstrating his commitment to integrating technology in pathology. Furthermore, his active participation in professional societies, such as the International Academy of Pathology, reflects his dedication to collaboration and knowledge sharing within the global pathology community.

Publications:

  1. Evaluation of PD-L1 expression in PBRM1-altered clear cell renal cell carcinoma
    • Authors: Jieun Lee, Seyoung Moon, Hyun Jung Kwon, Sejoon Lee, Gheeyoung Choe, Kyu Sang Lee
    • Year: 2024
  2. An artificial intelligence‐powered PD‐L1 combined positive score (CPS) analyser in urothelial carcinoma alleviating interobserver and intersite variability
    • Authors: Kyu Sang Lee, Euno Choi, Soo Ick Cho, Seonwook Park, Jeongun Ryu, Aaron Valero Puche, Minuk Ma, Jongchan Park, Wonkyung Jung, Juneyoung Ro, et al.
    • Year: 2024
  3. IDH -wildtype secondary glioblastoma arising in IDH -mutant diffuse astrocytoma: a case report
    • Authors: Byul-Hee Yoon, Ju Sang Park, Seongmin Kang, Nak-Jung Kwon, Kyu Sang Lee, Chae‑Yong Kim, Gheeyoung Choe
    • Year: 2023
  4. Verrucous Carcinoma of the Toenail: A Case Report and Review of Literature
    • Authors: Jong-Ho Kim, Jinil Choi, Joseph Kyu-hyung Park, Jeonghyo Lee, Kyu Sang Lee, Baek-Kyu Kim
    • Year: 2022
  5. Sporadic Intradural Extramedullary Hemangioblastoma Not Associated with von Hippel-Lindau Syndrome: A Case Report and Literature Review
    • Authors: Mi-Kyung Um, Eugene Lee, Joon Woo Lee, Kyu Sang Lee, Yusuhn Kang, Joong Mo Ahn, Heung Sik Kang
    • Year: 2021
  6. Effects of low-level laser therapy and adipose-derived stem cells on the viability of autologous fat grafts: a preliminary study
    • Authors: Chan Yeong Heo, Young Soo Yoon, Kyung Hee Min, Sun Young Nam, Kyu Sang Lee, Byung Ho Shin, Seunghee Lee, Miji Lee
    • Year: 2021
  7. Persistent expression of interleukin‐17 and downstream effector cytokines in recalcitrant psoriatic lesions after ustekinumab treatment
    • Authors: Bo Ri Kim, Minsu Kim, Seungkeol Yang, Chong Won Choi, Kyu Sang Lee, Sang Woong Youn
    • Year: 2021
  8. Spinal Intraosseous Hibernoma: A Case Report and Review of Literature
    • Authors: Mi-Kyung Um, Eugene Lee, Joon Woo Lee, Kyu Sang Lee, Yusuhn Kang, Joong Mo Ahn, Heung Sik Kang
    • Year: 2020
  9. Comparative analysis of programmed cell death ligand 1 assays in renal cell carcinoma
    • Authors: Kyu Sang Lee, Gheeyoung Choe, Sumi Yun, Kyoungyul Lee, Seyoung Moon, Sangchul Lee, Sung Kyu Hong, Seok‐Soo Byun, Sang Eun Lee
    • Year: 2020
  10. The role of pathologists in multidisciplinary cancer care
    • Authors: Kyu Sang Lee, Gheeyoung Choe
    • Year: 2016